Skip to content

Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation

Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03229655
Enrollment
100
Registered
2017-07-25
Start date
2017-09-01
Completion date
2022-09-01
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Stenosis, Biliary Stricture

Brief summary

Prospective, randomized comparison of the incremental dilation and stent exchange vs. sequential stent addition approaches for management of anastomotic biliary strictures will facilitate optimal management of patients who develop anastomotic biliary strictures after liver transplantation.

Interventions

PROCEDUREProtocol for increasing number of stents across the anastomosis

Sequential placement of straight plastic biliary stents across the duct-to-duct anastomosis without dilation or stent exchange. Multiple ERCPs will be performed with addition of a single stent at each ERCP until the final ERCP when all stents will be removed.

Sponsors

University of Rochester
CollaboratorOTHER
University of Barcelona
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized prospective study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 and older 2. Clinical concern for anastomotic biliary stricture following liver transplantation (as determined by the referring transplant hepatologist) 3. Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

1. Age \<18 2. Potentially vulnerable subjects including, homeless people, pregnant females, employees and students. 3. Complex post-surgical anatomy e.g. Choledochojejunostomy, Billroth type II anatomy, Roux-en-Y-gastrojejunostomy 4. Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit 5. Other biliary process which accounts for patient's abnormal liver function studies/imaging (i.e. significant non-anastomotic biliary stricture).

Design outcomes

Primary

MeasureTime frameDescription
Anastomotic biliary stricture resolutionImmediately following final ERCP with stent removalFluoroscopic (on ERCP image) resolution of stricture at the time of final study ERCP when all stents are removed

Secondary

MeasureTime frameDescription
Fluoroscopy Parameters1 dayFluoroscopy Time per fluoroscopy machine output
Adverse Events1 weekPancreatitis, bleeding, infection, perforation to be assessed one day and one week post-procedure
Sustained resolution of anastomotic stricture for 6 months6 months after final study ERCP with stent removalNo evidence of recurrent stricture based on clinical status and laboratory studies
Sustained resolution of anastomotic stricture for 12 months12 months after final study ERCP with stent removalNo evidence of recurrent stricture based on clinical status and laboratory studies

Countries

United States

Contacts

Primary ContactSubhas Banerjee, MD
sbanerje@stanford.edu650-723-2623

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026